Donaldson Co Inc (STU:DNZ)
€ 80 -0.50 (-0.62%) Market Cap: 9.37 Bil Enterprise Value: 9.72 Bil PE Ratio: 24.72 PB Ratio: 6.28 GF Score: 71/100

Q3 2025 Donaldson Company Inc Earnings Call Transcript

Jun 03, 2025 / 02:00PM GMT
Release Date Price: €61 (+1.67%)

Key Points

Positve
  • Donaldson Co Inc (DCI) achieved record sales and adjusted earnings despite macroeconomic uncertainties.
  • The company announced an 11% increase in its quarterly dividend, reflecting strong financial health.
  • Sales growth was observed across all three segments, with significant contributions from the aftermarket business.
  • The aerospace and defense segment reached an all-time high in sales, showcasing strong market demand.
  • Donaldson Co Inc (DCI) maintained a strong balance sheet, enabling significant share repurchases and strategic investments.
Negative
  • The company faced a $62 million impairment charge related to intangible assets in its bioprocessing businesses.
  • Gross margin decreased by 110 basis points due to higher manufacturing costs and footprint optimization initiatives.
  • First-fit businesses in developed regions are experiencing cyclical headwinds, particularly in the transportation and agriculture markets.
  • The bioprocessing segment continues to face market headwinds, impacting sales and profitability.
  • Currency translation posed a headwind, partially offsetting sales growth.
Operator

(Operator Instructions)

Good morning and welcome to Donaldson's third quarter fiscal 2025 earnings conference call and webcast. (Operator Instructions) Today's conference is being recorded.

I would now like to turn the call over to Sarika Dhadwal, Senior Director of Investor Relations and ESG. Please go ahead.

Sarika Dhadwal
Donaldson Company Inc - Senior Director of Investor Relations and ESG

Good morning. Thank you for joining Donaldson's third quarter fiscal 2025 earnings conference call. With me today are Tod Carpenter, Chairman, President and CEO; and Brad Pogalz, Chief Financial Officer. This morning, Tod and Brad will provide a summary of our third quarter performance and our updated outlook for fiscal 2025. During today's call, we will discuss non-GAAP or adjusted results.

For third quarter 2025 non-GAAP results exclude pre-tax charges of $62 million for the impairment of certain intangible assets for our two upstream bioprocessing businesses, Univercells Technologies and Solaris. Results also exclude pre-tax charges of $4

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot